	SLOG versus modified FOLFIRINOX as first-line treatment for advanced pancreatic cancer: A randomized phase II trial (TCOG T5217). Eur J Cancer Chiang NJ, Su YY, Ho IW, Bai LY, Li CP, Chen JS, Hsiao CF, Tsou HH, Hsu C, Chiu TJ, Hsieh YY, Rau KM, Ho CL, Shan YS, Chen LT. PMID: 41576645 [PubMed - as supplied by publisher]
	Prognostic role and clinicopathological features of SMAD4 gene mutation in pancreatic cancer: a systematic review and meta-analysis. Cancer Treat Res Commun Rodrigues T, Albuquerque J, Cardoso J, Sousa-Ferreira I, Martins JP, Coelho JLP. PMID: 41576526 [PubMed - as supplied by publisher]
	Threshold Dose-Response Association Between Alcohol Consumption and Risk of Young-Onset Pancreatic Cancer: A Nationwide Korean Cohort Study of Young Adults Age 20-39 Years. J Clin Oncol Park JH, Hong JY, Han K, Shen JJ, Park JO, Park YS, Lim HY. PMID: 41576296 [PubMed - as supplied by publisher]
	Exploring correlations of CA19-9 with serum enzyme ratios: can layered biomarker strategies enhance prognostic accuracy in pancreatic cancer? Clin Transl Oncol Saini A, Mehta M, Mehta DK, Roy KK, Das R. PMID: 41575662 [PubMed - as supplied by publisher]
	Gadoxetic Acid-enhanced MRI Radiomics Features of Tumor Margins for Predicting High-Risk Solitary Hepatocellular Carcinoma Aggressiveness and Prognosis. Radiol Imaging Cancer Yu C, Wang X, Tang S, Li Y, Han S, Zhang Q, Qu J, Xu H, Zhou Y. PMID: 41575341 [PubMed - indexed for MEDLINE]
	Digitally derived Ki-67 proliferation index for GastroEnteroPancreatic neuroendocrine neoplasms. Pathol Oncol Res Micsik T, Csellár L, Patai ÁV, Jakab A, Jónás V, Molnár B. PMID: 41574207 [PubMed - indexed for MEDLINE]
	Portuguese Pancreatic Club Perspective on Epidemiology, Classification, and Natural History of Pancreatic Intraductal Papillary Mucinous Neoplasms. GE Port J Gastroenterol Bravo AC, Cruz R, Fernandes A, Bispo M, Vilas-Boas F, Gonçalves TC, Rodrigues-Pinto E, Fidalgo C. PMID: 41573107 [PubMed - as supplied by publisher]
	Ga-68-Edotreotide PET/CT SSTR Total Tumor Volume as a Predictor of Outcome in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors. Cancer Control Gallicchio R, Milella M, Giordano A, Cives M, Storto R, Nardelli A, Calice G, Landriscina M, Storto G. PMID: 41572131 [PubMed - indexed for MEDLINE]
	Pain at the end of life in patients with cancer: a population-based study on prevalence, relief, and the role of pain assessment. Support Care Cancer Slotman E, Hedman C, Fransen HP, van der Linden YM, Raijmakers NJH, Lundström S. PMID: 41571835 [PubMed - indexed for MEDLINE]
	Patient experience with endoscopic ultrasound and magnetic resonance cholangiopancreatography for pancreatic cancer screening (The PATRIOT study). Pancreatology Silva-Santisteban Merino A, Ariza Manzano KE, Ballou S, Bezuidenhout AF, Germansky KA, Sawhney MS. PMID: 41571577 [PubMed - as supplied by publisher]
	Subtype-specific characteristics and outcomes of liposarcoma: A population-based study using Japan's National Cancer Registry. J Orthop Sci Kondo H, Ogura K, Morizane C, Satake T, Iwata S, Toda Y, Muramatsu S, Takemori T, Kobayashi E, Higashi T, Kawai A. PMID: 41571566 [PubMed - as supplied by publisher]
	Feasibility of a mobile application-based geriatric assessment and communication support intervention for older adults with cancer: protocol for a pilot randomised controlled trial (MAPLE2 pilot). BMJ Open Matsuoka A, Konishi Y, Boku N, Takashima A, Okusaka T, Mori K, Akechi T, Tsubata Y, Majima Y, Uchitomi Y, Nagashima F, Fujimori M. PMID: 41571409 [PubMed - indexed for MEDLINE]
	Phase 1b/2 study of BMS-813160, a CCR2/5 dual antagonist, in combination with chemotherapy or nivolumab in patients with advanced pancreatic or colorectal cancer. J Immunother Cancer Le DT, Folprecht G, Varghese AM, Gutierrez M, Noel M, Trikalinos NA, Chen E, Dayyani F, Davis SL, Ma WW, BasuMallick A, Garrido-Laguna I, Osawa M, O'Brien S, Novosiadly RD, Xu K, Greenawalt DM, Dutta S, Twyman Saint Victor C, Lenz HJ. PMID: 41571299 [PubMed - indexed for MEDLINE]
	Real World Evidence of Clinical Outcomes of First-Line Chemotherapy in Locally Advanced and Metastatic Pancreatic Adenocarcinoma Patients. Asian Pac J Cancer Prev Umpawan N, Termsinsuk P, Kaosombatwattana U, Akewanlop C, Korphaisarn K. PMID: 41569206 [PubMed - indexed for MEDLINE]
	Targeted photodynamic therapy for pancreatic cancer: recent innovations from fundamentals to in vivo and clinical applications (2020-2025). Chem Commun (Camb) Sarr S, Godard J, Valzer E, Czuba E, Acherar S, Barberi-Heyob M, Blanchard-Desce M, Boleslawski E, Brégier F, Bulin AL, Burckel H, Daouk J, da Silva A, Daniel J, Delhem N, Dewalle AS, Frochot C, Gasser G, Heitz V, Jonckheere N, Lemercier G, Mordon S, Noël G, Novell A, Ravanat JL, Roth G, Sol V. PMID: 41568579 [PubMed - as supplied by publisher]
	Endoscopic ultrasound molecular evaluation of pancreatic cancer trial to profile molecular landscape of inoperable pancreatic ductal adenocarcinoma. Endosc Int Open McKay O, Lundy J, Bell S, Ha P, Gao H, Jenkins B, Bulathsinghalage C, Swan M, Hew S, Lee B, Dorwal P, Bhutani MS, Rathi V, Grimmond S, Perry A, Wilson T, Strickland A, Zalcberg J, Croagh D. PMID: 41567498 [PubMed]
	Simple appendectomy is a safe and effective surgical approach for low-grade appendiceal mucinous neoplasm at the appendiceal root with negative margins: a retrospective comparative cohort study. World J Surg Oncol Han Z, Tan W, Xing C, Ge Y, Guo S, Zhong H, Zheng Y, Zhou Y, Song J. PMID: 41566517 [PubMed - as supplied by publisher]
	Lenvatinib plus transarterial chemoembolization and PD-1 inhibitors as conversion therapies for unresectable intermediate-advanced hepatocellular carcinoma: a phase 2 trial and exploratory biomolecular study. Signal Transduct Target Ther Zhang X, Cai H, Peng W, Wang H, Wu J, Zhu X, Guo W, Xie F, Zhang Y, Wang M, Yu Y, Zhou Y, Li C, Shen J, Liu C, Yang Y, Jiang X, Li Q, Chen W, Shi Y, Lu W, Sun X, Feng X, Yan M, Cheng S, Wen T. PMID: 41565617 [PubMed - indexed for MEDLINE]
	The role of the hedgehog signaling pathway in the regulation of gastrointestinal cancer cell death. Cell Signal Zang W, Zhu W, Jing F, Qi H, Ma X, Wang Y, Jia Y. PMID: 41565191 [PubMed - as supplied by publisher]
	C2HFusion: Clinical context-driven hierarchical fusion of multimodal data for personalized and quantitative prognostic assessment in pancreatic cancer. Med Image Anal Zeng B, Xu Y, Wang P, Lu T, Xie Z, Zeng M, Zhou J, Liu L, Sun H, Chen X. PMID: 41564638 [PubMed - as supplied by publisher]

Articles 1 - 20 / 58833

Page 1 of 2942



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy